---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-070316"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2026-06-22T10:05:49+00:00"
generated_at: "2026-06-22T10:10:26.412001+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Unicycive stockholders re-elect three directors and ratify auditor at 2026 annual meeting

## Summary
- Directors elected: Dr. Shalabh Gupta (8.13M for, 174k withhold), Dr. Sandeep Laumas (7.70M for, 610k withhold), D. Sarawati Kenkare-Mitra (7.51M for, 795k withhold).
- Ratification of Grassi & Co. as auditor for FY 2026 passed with 14.67M for, 287k against, 10k abstentions.
- 14,964,159 shares represented at the meeting, constituting a quorum.
- Broker non-votes totaled approximately 6.66M shares on each director election.

## SEC filing metadata
- accession: 0001213900-26-070316
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2026-06-22T10:05:49+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390026070316/0001213900-26-070316-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390026070316/ea0295382-8k_unicycive.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-070316
- JSON: https://secwatch.observer/filing/0001213900-26-070316.json
- Plain text: https://secwatch.observer/filing/0001213900-26-070316.txt

## Key facts
- Shareholder Votes
  Unicycive Therapeutics, Inc. shareholders approved Ratification of appointment of Grassi & Co. CPAs, P.C. as independent registered public accounting firm for fiscal year 2026 at the 2025-06-19 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2025-06-19
  source text: The appointment of Grassi & Co. CPAs, P.C. as the Company’s independent registered public accounting firm for its fiscal year ended December 31, 2026 was ratified and approved by the stockholders by the votes set forth in the table below: For Against Abstain Broker Non Vote 14,667,242 286,958 9,928 31
  evidence_url: https://www.sec.gov/Archives/edgar/data/1766140/000121390026070316/0001213900-26-070316-index.htm
- Shareholder Votes
  Unicycive Therapeutics, Inc. shareholders approved Election of three nominees for director at the 2025-06-19 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2025-06-19
  source text: On June 19, 2025, Unicycive Therapeutics, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1766140/000121390026070316/0001213900-26-070316-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.